University of California Irvine-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of California Irvine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013484
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of California Irvine (UCI), a subsidiary of University of California is an educational university that provides undergraduate and graduate degree courses and research services. The university provides educational courses in various fields such as business, education, engineering, arts, biological sciences, and school of medicine, social ecology, program in nursing science, interdisciplinary studies, law, medicine, public health, humanities, information and computer sciences; social sciences, pharmaceutical sciences, and physical sciences, among others. The university also supports, promotes and facilitates various research activities. It operates various research activities with the help of research institutions. The university also provides training and education on research activities. UCI is headquartered in Irvine, California, the US.

University of California Irvine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Irvine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Irvine, Medical Devices Deals, 2011 to YTD 2017 9
University of California Irvine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of California Irvine, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novoheart Enters into Research Agreement with University of California Irvine 11
Licensing Agreements 12
Novoheart Enters into Licensing Agreement with University of California Irvine 12
Thesan Pharma Enters into Licensing Agreement with University of California, Irvine 13
ChromaDex Enters Into Licensing Agreement With University Of California, Irvine 14
Repligen Enters Into Licensing Agreement With UCI 15
University of California Irvine – Key Competitors 16
University of California Irvine – Key Employees 17
University of California Irvine – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Government and Public Interest 20
Sep 18, 2017: UCI receives $200 million gift to name College of Health Sciences and launch major integrative health initiative 20
Jul 26, 2017: UCI Stem Cell Therapy Attacks Cancer by Targeting Unique Tissue Stiffness 22
Aug 01, 2016: UCI scientists identify a new approach for treating skin cancer 23
Mar 28, 2016: UCI scientists receive $8 million to help develop Q fever vaccine 24
Feb 29, 2016: Genetic Link to Parkinson’s Disease Is Best Hope for the Future in Rare Disease 25
Product News 26
Jul 05, 2016: Unique Alzheimer’s Disease Vaccines Show Great Potential in Pre-Clinical Studies 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
University of California Irvine, Pharmaceuticals & Healthcare, Key Facts 2
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Irvine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Irvine, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Irvine, Medical Devices Deals, 2011 to YTD 2017 9
University of California Irvine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novoheart Enters into Research Agreement with University of California Irvine 11
Novoheart Enters into Licensing Agreement with University of California Irvine 12
Thesan Pharma Enters into Licensing Agreement with University of California, Irvine 13
ChromaDex Enters Into Licensing Agreement With University Of California, Irvine 14
Repligen Enters Into Licensing Agreement With UCI 15
University of California Irvine, Key Competitors 16
University of California Irvine, Key Employees 17
University of California Irvine, Subsidiaries 18

★海外企業調査レポート[University of California Irvine-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ingeniatrics Tecnologias, S.L.(製薬・医療分野):企業M&A動向
    Summary Ingeniatrics Tecnologias, S.L. (Ingeniatrics Tecnologias) is a manufacturer of medical devices. The company through its own industrial technology carries out the production of nebulizers. Its product portfolio includes nebulizers, cellena, oneNeb, core-shell-shell capsules, and multiplexed l …
  • Athenex Inc (ATNX)-製薬・医療分野:企業M&A・提携分析
    Summary Athenex Inc (Athenex), formerly Kinex Pharmaceuticals LLC is a drug manufacturing and distributing company that distributes therapies for cancer diseases and supportive therapies. The company offers drug discovery, drug formulation and clinical development. It offers products such as ointmen …
  • SSA Marine, Inc.:企業概要及び戦略的SWOT分析
    SSA Marine, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • BNP Paribas SA:企業の戦略・SWOT・財務分析
    BNP Paribas SA - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ONEOK Partners LP:石油・ガス:M&Aディール及び事業提携情報
    Summary ONEOK Partners, L.P. (ONEOK Partners), a subsidiary of Oneok, Inc., is a midstream energy company. The company carries out gathering, processing, and storage and transportation of natural gas. It operates through master limited partnerships. ONEK Partners owns natural gas liquids (NGL) syste …
  • Aiful Corporation:企業の戦略・SWOT・財務情報
    Aiful Corporation - Strategy, SWOT and Corporate Finance Report Summary Aiful Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shengli Oil and Gas Pipe Holdings Ltd:企業の戦略・SWOT・財務分析
    SummaryShengli Oil and Gas Pipe Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • Zhejiang Hisoar Pharmaceutical Co Ltd (002099):企業のM&A・提携動向(医療分野)
    Summary Zhejiang Hisoar Pharmaceutical Co Ltd (Hisoar) is a manufacturer and distributor of fine chemicals and special raw drugs. The company offers raw drugs, which include antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs for both humans and animals. It produces fine chemi …
  • Yantai Dongcheng Pharmaceutical Group Co Ltd (002675):製薬・医療:M&Aディール及び事業提携情報
    Summary Yantai Dongcheng Pharmaceutical Group Co Ltd (Yantai Dongcheng Pharma), formerly Yantai Dongcheng Biochemicals Co Ltd, is a developer, manufacturer, and marketer of biochemical API, chemical synthetic drugs, and Chinese medicines. The company offers its products under categories including he …
  • Loblaw Companies Limited:企業概要・SWOT・財務分析
    Summary Canadean's "Loblaw Companies Limited : Retailing - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, …
  • Suzhou Xinrong Best Medical Instrument Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Suzhou Xinrong Best Medical Instrument Co Ltd (Suzhou Xinrong) is a medical device company that manufactures orthopedic medical instruments. The company offers products such as medullary cavity plug, acetabular screws, metal ball head, stem and titanium plate anterior thoracolumbar fixed equ …
  • Telekom Slovenije, d.d. (TLSG):企業の財務・戦略的SWOT分析
    Telekom Slovenije, d.d. (TLSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Blistex Inc.:企業の戦略・SWOT・財務分析
    SummaryBlistex Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • Shanda Interactive Entertainment Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shanda Interactive Entertainmen …
  • Epistar Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Epistar Corporation Mergers and …
  • DSW Inc.:戦略・SWOT・企業財務分析
    DSW Inc. - Strategy, SWOT and Corporate Finance Report Summary DSW Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Kesoram Industries Limited:企業の戦略・SWOT・財務分析
    SummaryKesoram Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Societe Nationale d’Operations Petrolieres de la Cote d’Ivoire:企業のM&A・提携動向(石油・ガス分野)
    Summary Societe Nationale d'Operations Petrolieres de la Cote d'Ivoire (Petroci) is a petroleum company that explores, produces, transports, stores and trades petroleum products and by-products. The company offers buthane gas, natural gas and LPG. Its services include uphill, promotion, exploration, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆